Reply to Comment on “UGT2B17 modifies drug response in chronic lymphocytic leukaemia”

Detalles Bibliográficos
Autores principales: Guillemette, Chantal, Rouleau, Michèle, Vanura, Katrina, Lévesque, Éric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553966/
https://www.ncbi.nlm.nih.gov/pubmed/32704176
http://dx.doi.org/10.1038/s41416-020-1006-4
_version_ 1783593713665048576
author Guillemette, Chantal
Rouleau, Michèle
Vanura, Katrina
Lévesque, Éric
author_facet Guillemette, Chantal
Rouleau, Michèle
Vanura, Katrina
Lévesque, Éric
author_sort Guillemette, Chantal
collection PubMed
description
format Online
Article
Text
id pubmed-7553966
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-75539662021-07-24 Reply to Comment on “UGT2B17 modifies drug response in chronic lymphocytic leukaemia” Guillemette, Chantal Rouleau, Michèle Vanura, Katrina Lévesque, Éric Br J Cancer Correspondence Nature Publishing Group UK 2020-07-24 2020-10-13 /pmc/articles/PMC7553966/ /pubmed/32704176 http://dx.doi.org/10.1038/s41416-020-1006-4 Text en © Cancer Research UK 2020 https://creativecommons.org/licenses/by/4.0/Note This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).
spellingShingle Correspondence
Guillemette, Chantal
Rouleau, Michèle
Vanura, Katrina
Lévesque, Éric
Reply to Comment on “UGT2B17 modifies drug response in chronic lymphocytic leukaemia”
title Reply to Comment on “UGT2B17 modifies drug response in chronic lymphocytic leukaemia”
title_full Reply to Comment on “UGT2B17 modifies drug response in chronic lymphocytic leukaemia”
title_fullStr Reply to Comment on “UGT2B17 modifies drug response in chronic lymphocytic leukaemia”
title_full_unstemmed Reply to Comment on “UGT2B17 modifies drug response in chronic lymphocytic leukaemia”
title_short Reply to Comment on “UGT2B17 modifies drug response in chronic lymphocytic leukaemia”
title_sort reply to comment on “ugt2b17 modifies drug response in chronic lymphocytic leukaemia”
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553966/
https://www.ncbi.nlm.nih.gov/pubmed/32704176
http://dx.doi.org/10.1038/s41416-020-1006-4
work_keys_str_mv AT guillemettechantal replytocommentonugt2b17modifiesdrugresponseinchroniclymphocyticleukaemia
AT rouleaumichele replytocommentonugt2b17modifiesdrugresponseinchroniclymphocyticleukaemia
AT vanurakatrina replytocommentonugt2b17modifiesdrugresponseinchroniclymphocyticleukaemia
AT levesqueeric replytocommentonugt2b17modifiesdrugresponseinchroniclymphocyticleukaemia

Ejemplares similares